Primary study · included by 1 review

A Phase 2 Study Evaluating the Efficacy and Safety of a Novel, Proprietary, Nano-Formulated, Lower Dose Oral Diclofenac

Manvelian 2012 · Manvelian Garen, Daniels Stephen, Gibofsky Allan · Pain Medicine · 2012

Included by

Cyclooxygenase-2 selective inhibitors increase the risk of alveolar osteitis: A systematic review and meta-analysis.
Non-Cochrane · intervention · 2026 · cited as Manvelian 2012 · Reference [54]; Figures 1-2
Outcome this study informsPooled effectEvidenceCertainty
Alveolar osteitis (dry socket) occurrence
Diclofenac vs Placebo or untreated control
OR 1.83 [0.67, 5.04]3 studies · 641 participantsGRADE not reported
Alveolar osteitis (dry socket) occurrence
Celecoxib vs Placebo or untreated control
OR 0.28 [0.15, 0.52]3 studies · 682 participantsGRADE not reported

1 including review in total.